DSOL logo

Drug Free Solution, Inc. (DSOL)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Drug Free Solution, Inc. (DSOL) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 45/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 16. März 2026
45/100 KI-Bewertung

Drug Free Solution, Inc. (DSOL) Gesundheitswesen & Pipeline-Uebersicht

CEOJessica Bass
HauptsitzEl Segundo, US
IPO-Jahr2012

Drug Free Solution, Inc. delivers emotional wellness technology, the Living Breath Process, targeting addiction prevention, self-help, and lifestyle markets. The company offers programs, education, and services through its Living Breath Series and aims to establish community wellness centers and support networks. It operates within the healthcare information services sector.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 16. März 2026

Investmentthese

Drug Free Solution, Inc. presents a unique approach to emotional wellness through its Living Breath Process. The company's focus on addiction prevention and self-help markets positions it within a growing segment of the healthcare industry. Key value drivers include the expansion of its Living Breath Series programs and the establishment of community wellness centers. However, the company's small market capitalization of $0.00B and negative P/E ratio of -59.29 indicate financial challenges. Future success depends on the company's ability to effectively market its programs, secure partnerships, and demonstrate tangible results in reducing addiction and improving emotional wellness. The company's beta of 0.07 suggests low volatility relative to the market.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.00B reflects the company's small size and limited market presence.
  • P/E ratio of -59.29 indicates that the company is currently not profitable.
  • Beta of 0.07 suggests low volatility compared to the overall market.
  • The company's focus on emotional wellness aligns with growing demand for mental health solutions.
  • The Living Breath Process represents a proprietary technology with potential for expansion into various markets.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Proprietary Living Breath Process technology.
  • Focus on addiction prevention and emotional wellness.
  • Potential for community-based partnerships.
  • Experienced leadership team.

Schwaechen

  • Small market capitalization and limited financial resources.
  • Negative P/E ratio indicating lack of profitability.
  • Limited brand recognition compared to larger competitors.
  • Dependence on a single core technology.

Katalysatoren

  • Ongoing: Expansion of Living Breath Series programs to new markets and demographics.
  • Ongoing: Establishment of community wellness centers in strategic locations.
  • Ongoing: Partnerships with correctional facilities to implement the Living Breath Project.
  • Upcoming: Development and launch of a digital platform for online delivery of the Living Breath Process (timeline: 1-2 years).
  • Upcoming: Launch of corporate wellness programs based on the Living Breath Process (timeline: 1-2 years).

Risiken

  • Potential: Competition from established players in the wellness market.
  • Potential: Changes in regulations related to addiction treatment and mental health.
  • Potential: Economic downturn affecting consumer spending on wellness products.
  • Potential: Technological advancements disrupting the market.
  • Ongoing: Limited financial resources and lack of profitability.

Wachstumschancen

  • Expansion of the Living Breath Series: The company can expand its Living Breath Series of programs to reach a broader audience. This includes developing new products, educational materials, and services tailored to specific demographics and needs. The global self-help market is projected to reach $14 billion by 2027, providing a significant opportunity for growth. Timeline: Ongoing.
  • Establishment of Community Wellness Centers: Drug Free Solution can establish community wellness centers in strategic locations to provide access to its Living Breath Process and related services. These centers can serve as hubs for community engagement and offer a range of wellness programs. The market for community-based wellness programs is growing, driven by increasing awareness of the importance of social support in mental health. Timeline: Ongoing.
  • Partnerships with Correctional Facilities: The company can partner with correctional facilities to implement its Living Breath Project and reduce addiction and incarceration rates. This includes providing training, education, and support networks for inmates and staff. The market for correctional healthcare services is substantial, with significant potential for innovative programs that address addiction and mental health. Timeline: Ongoing.
  • Digital Platform Development: Creating a digital platform to deliver the Living Breath Process online can significantly expand the company's reach and accessibility. This platform can offer virtual coaching, online courses, and interactive tools to support emotional wellness. The digital health market is experiencing rapid growth, with increasing adoption of telehealth and virtual wellness solutions. Timeline: 1-2 years.
  • Corporate Wellness Programs: Offering corporate wellness programs based on the Living Breath Process can tap into the growing demand for employee mental health support. These programs can help reduce stress, improve productivity, and enhance employee well-being. The corporate wellness market is expanding, with companies increasingly investing in mental health benefits for their employees. Timeline: 1-2 years.

Chancen

  • Expansion of Living Breath Series programs.
  • Establishment of community wellness centers.
  • Partnerships with correctional facilities.
  • Development of a digital platform for online delivery.

Risiken

  • Competition from established players in the wellness market.
  • Changes in regulations related to addiction treatment and mental health.
  • Economic downturn affecting consumer spending on wellness products.
  • Potential for technological advancements to disrupt the market.

Wettbewerbsvorteile

  • Proprietary Living Breath Process technology.
  • Focus on community-based wellness initiatives.
  • Potential for partnerships with correctional facilities.
  • Brand recognition within the emotional wellness market.

Ueber DSOL

Drug Free Solution, Inc., formerly known as Living Breath Project, Inc., is a lifestyle company founded to provide emotional wellness solutions. The company's core offering is the Living Breath Process, a three-step method incorporating self-analysis, breathwork, and language techniques. This process is designed to address various markets, including addiction prevention, self-help, emotional wellness, and general lifestyle enhancement. Drug Free Solution offers the Living Breath Series, a suite of programs, products, education, and services centered around this proprietary process. The company's Living Breath Project aims to establish community wellness centers, wellness homes, and correctional facility support networks. These initiatives combine the company's offerings to reduce addiction and incarceration rates in the United States. Incorporated in January 2014, Drug Free Solution, Inc. is based in El Segundo, California, and continues to develop and expand its reach within the emotional wellness market.

Was das Unternehmen tut

  • Delivers proprietary emotional wellness technology known as Living Breath Process.
  • Offers a three-step process combining self-analysis, breath, and language.
  • Targets addiction/prevention, self-help, emotional wellness, and lifestyle markets.
  • Provides the Living Breath Series of programs with products, education, and services.
  • Focuses on creating community wellness centers and wellness homes.
  • Establishes correctional facility support networks and centers.
  • Aims to diminish addiction and incarceration rates in the United States.

Geschaeftsmodell

  • Sales of Living Breath Series programs, products, and services.
  • Revenue from training and education programs related to the Living Breath Process.
  • Partnerships with community wellness centers and correctional facilities.
  • Potential revenue from corporate wellness programs.

Branchenkontext

Drug Free Solution, Inc. operates within the healthcare information services sector, which is experiencing growth due to increasing awareness of mental health and the demand for accessible wellness solutions. The market is competitive, with numerous companies offering various approaches to emotional wellness and addiction prevention. Competitors include companies like AHGIF (American Green, Inc.), CBSTF (Cannabics Pharmaceuticals Inc.), CYYNF (Canna-Global Acquisition Corp), ITHUF (Isracann Biosciences Inc.), and LEEEF (Laredo Oil Inc.). Drug Free Solution differentiates itself through its proprietary Living Breath Process and its focus on community-based wellness initiatives.

Wichtige Kunden

  • Individuals seeking addiction prevention and self-help solutions.
  • Community wellness centers and organizations.
  • Correctional facilities and support networks.
  • Corporations looking to improve employee wellness.
KI-Zuversicht: 70% Aktualisiert: 16. März 2026

Finanzdaten

Chart & Info

Drug Free Solution, Inc. (DSOL) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer DSOL.

Kursziele

Wall-Street-Kurszielanalyse fuer DSOL.

MoonshotScore

45/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von DSOL auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Jessica Bass

CEO

Jessica Bass serves as the CEO of Drug Free Solution, Inc. Her background includes experience in the wellness and lifestyle sectors. She has a track record of developing and implementing innovative programs focused on emotional well-being and addiction prevention. Her expertise lies in creating community-based initiatives and partnerships to promote holistic health. She is committed to expanding the reach of the Living Breath Process and making it accessible to a wider audience.

Erfolgsbilanz: Under Jessica Bass's leadership, Drug Free Solution, Inc. has focused on expanding its Living Breath Series programs and establishing partnerships with community organizations. She has overseen the development of new educational materials and services related to the Living Breath Process. Her strategic decisions have aimed to increase the company's visibility and impact within the emotional wellness market.

DSOL OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Drug Free Solution, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and liquidity.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Given that DSOL trades on the OTC Other tier, liquidity is likely limited. This means that trading volume may be low, and the bid-ask spread could be wide. Investors may experience difficulty buying or selling shares at desired prices, especially in large quantities. The lack of liquidity increases the risk of price volatility and potential losses.
OTC-Risikofaktoren:
  • Limited financial disclosure increases the risk of investing in DSOL.
  • Low trading volume and wide bid-ask spread can lead to price volatility.
  • The OTC Other tier indicates a higher risk of fraud or manipulation.
  • Lack of regulatory oversight compared to major exchanges.
  • Potential for delisting or suspension of trading.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's revenue streams and profitability.
  • Check for any legal or regulatory issues.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor before investing.
Legitimitaetssignale:
  • The company has a registered business address in El Segundo, California.
  • The company has a CEO (Jessica Bass) with a background in the wellness sector.
  • The company has a proprietary technology (Living Breath Process).
  • The company has been in operation since 2014 (formerly Living Breath Project, Inc.).

DSOL Healthcare Aktien-FAQ

What are the key factors to evaluate for DSOL?

Drug Free Solution, Inc. (DSOL) currently holds an AI score of 45/100, indicating low score. Key strength: Proprietary Living Breath Process technology.. Primary risk to monitor: Potential: Competition from established players in the wellness market.. This is not financial advice.

How frequently does DSOL data refresh on this page?

DSOL prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven DSOL's recent stock price performance?

Recent price movement in Drug Free Solution, Inc. (DSOL) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary Living Breath Process technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider DSOL overvalued or undervalued right now?

Determining whether Drug Free Solution, Inc. (DSOL) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying DSOL?

Before investing in Drug Free Solution, Inc. (DSOL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding DSOL to a portfolio?

Potential reasons to consider Drug Free Solution, Inc. (DSOL) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Proprietary Living Breath Process technology.. Additionally: Focus on addiction prevention and emotional wellness.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of DSOL?

Yes, most major brokerages offer fractional shares of Drug Free Solution, Inc. (DSOL) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track DSOL's earnings and financial reports?

Drug Free Solution, Inc. (DSOL) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for DSOL earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on available company descriptions and limited financial data.
  • OTC market data may be less reliable than data from major exchanges.
  • AI analysis is pending and may provide additional insights.
Datenquellen

Popular Stocks